Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Effects of The Cancer Genome Atlas

Dr Matthew Ellis - Washington University in St Louis, USA
Effects of The Cancer Genome Atlas ( Dr Matthew Ellis - Washington University in St Louis, USA )
2 Jun 2013

State of CNS germ cell tumour research in North America

Dr Stewart Goldman - Children's Memorial Hospital, Chicago, Illinois, USA
State of CNS germ cell tumour research in North America ( Dr Stewart Goldman	- Children's Memorial Hospital, Chicago, Illinois, USA )
29 May 2013

Possible consequences and potential for improvement for time of diagnosis for intracranial germ cell tumours

Dr Juliet Hale - Newcastle University, UK
Possible consequences and potential for improvement for time of diagnosis for intracranial germ cell tumours ( Dr Juliet Hale - Newcastle University, UK )
29 May 2013

miR 371-373 and miR 302 cluster expression in body fluids as potential biomarkers of malignant germ cell tumours

Dr Matthew Murray - Cambridge Cancer Centre, UK
miR 371-373 and miR 302 cluster expression in body fluids as potential biomarkers of malignant germ cell tumours ( Dr Matthew Murray - Cambridge Cancer Centre, UK )
29 May 2013

Time to diagnosis for intracranial germ cell tumours: Possible consequences and potential for improvement

Dr Juliet Hale - Newcastle University, UK
Time to diagnosis for intracranial germ cell tumours: Possible consequences and potential for improvement ( Dr Juliet Hale - Newcastle University, UK )
29 May 2013

Blood biopsies for tumour cell detection

Dr Alberto Bardelli - University of Torino Medical School, Turin, Italy
Blood biopsies for tumour cell detection ( Dr Alberto Bardelli - University of Torino Medical School, Turin, Italy )
29 May 2013

Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials ( Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
16 May 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013

Breast cancer heterogeneity no barrier to predictive testing

Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013

Single cell sequencing techniques in early and late breast cancer

Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA
Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013

Measurement variation influences gene expression profiles of breast cancer

Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013